Ph2 Gem/Nov/Rituxan Rel/Ref MantleCell

Clinical trial NCT00656084 · COMPLETED

Trial details

NCT number: NCT00656084
Sponsor: US Oncology Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Start date: 2004-12-01
Primary completion: 2007-01-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.